Atlas Trials

Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF

Clinical trial NCT03547583 · COMPLETED

Trial details

NCT number
NCT03547583
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Heart Failure With Preserved Ejection Fraction
Start date
2018-06-15
Primary completion
2019-10-15
Enrollment
789

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.